411 related articles for article (PubMed ID: 9398331)
1. A targeted library of small-molecule, tyrosine, and dual-specificity phosphatase inhibitors derived from a rational core design and random side chain variation.
Rice RL; Rusnak JM; Yokokawa F; Yokokawa S; Messner DJ; Boynton AL; Wipf P; Lazo JS
Biochemistry; 1997 Dec; 36(50):15965-74. PubMed ID: 9398331
[TBL] [Abstract][Full Text] [Related]
2. Parallel synthesis of a library of bidentate protein tyrosine phosphatase inhibitors based on the alpha-ketoacid motif.
Chen YT; Seto CT
Bioorg Med Chem; 2004 Jun; 12(12):3289-98. PubMed ID: 15158797
[TBL] [Abstract][Full Text] [Related]
3. Disruption of insulin-like growth factor-1 signaling and down-regulation of cdc2 by SC-alphaalphadelta9, a novel small molecule antisignaling agent identified in a targeted array library.
Vogt A; Rice RL; Settineri CE; Yokokawa F; Yokokawa S; Wipf P; Lazo JS
J Pharmacol Exp Ther; 1998 Nov; 287(2):806-13. PubMed ID: 9808713
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a potent, selective protein tyrosine phosphatase 1B inhibitor using a linked-fragment strategy.
Szczepankiewicz BG; Liu G; Hajduk PJ; Abad-Zapatero C; Pei Z; Xin Z; Lubben TH; Trevillyan JM; Stashko MA; Ballaron SJ; Liang H; Huang F; Hutchins CW; Fesik SW; Jirousek MR
J Am Chem Soc; 2003 Apr; 125(14):4087-96. PubMed ID: 12670229
[TBL] [Abstract][Full Text] [Related]
5. Identification of an essential acidic residue in Cdc25 protein phosphatase and a general three-dimensional model for a core region in protein phosphatases.
Eckstein JW; Beer-Romero P; Berdo I
Protein Sci; 1996 Jan; 5(1):5-12. PubMed ID: 8771191
[TBL] [Abstract][Full Text] [Related]
6. Identification of new Cdc25 dual specificity phosphatase inhibitors in a targeted small molecule array.
Ducruet AP; Rice RL; Tamura K; Yokokawa F; Yokokawa S; Wipf P; Lazo JS
Bioorg Med Chem; 2000 Jun; 8(6):1451-66. PubMed ID: 10896122
[TBL] [Abstract][Full Text] [Related]
7. Investigations of linker structure on the potency of a series of bidentate protein tyrosine phosphatase inhibitors.
Xie J; Seto CT
Bioorg Med Chem; 2005 Apr; 13(8):2981-91. PubMed ID: 15781408
[TBL] [Abstract][Full Text] [Related]
8. A novel strategy for the development of selective active-site inhibitors of the protein tyrosine phosphatase-like proteins islet-cell antigen 512 (IA-2) and phogrin (IA-2beta).
Drake PG; Peters GH; Andersen HS; Hendriks W; Møller NP
Biochem J; 2003 Jul; 373(Pt 2):393-401. PubMed ID: 12697028
[TBL] [Abstract][Full Text] [Related]
9. Small molecule inhibitors of dual specificity protein phosphatases.
Pestell KE; Ducruet AP; Wipf P; Lazo JS
Oncogene; 2000 Dec; 19(56):6607-12. PubMed ID: 11426646
[TBL] [Abstract][Full Text] [Related]
10. Solid-phase assembly and in situ screening of protein tyrosine phosphatase inhibitors.
Srinivasan R; Tan LP; Wu H; Yao SQ
Org Lett; 2008 Jun; 10(11):2295-8. PubMed ID: 18457404
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of a focused library of mitogen-activated protein kinase phosphatase inhibitors.
Arnold DM; Foster C; Huryn DM; Lazo JS; Johnston PA; Wipf P
Chem Biol Drug Des; 2007 Jan; 69(1):23-30. PubMed ID: 17313454
[TBL] [Abstract][Full Text] [Related]
12. VHR and PTP1 protein phosphatases exhibit remarkably different active site specificities toward low molecular weight nonpeptidic substrates.
Chen L; Montserat J; Lawrence DS; Zhang ZY
Biochemistry; 1996 Jul; 35(29):9349-54. PubMed ID: 8755712
[TBL] [Abstract][Full Text] [Related]
13. Small molecule interactions with protein-tyrosine phosphatase PTP1B and their use in inhibitor design.
Burke TR; Ye B; Yan X; Wang S; Jia Z; Chen L; Zhang ZY; Barford D
Biochemistry; 1996 Dec; 35(50):15989-96. PubMed ID: 8973169
[TBL] [Abstract][Full Text] [Related]
14. A model of Cdc25 phosphatase catalytic domain and Cdk-interaction surface based on the presence of a rhodanese homology domain.
Hofmann K; Bucher P; Kajava AV
J Mol Biol; 1998 Sep; 282(1):195-208. PubMed ID: 9733650
[TBL] [Abstract][Full Text] [Related]
15. Selective protein tyrosine phosphatase 1B inhibitors: targeting the second phosphotyrosine binding site with non-carboxylic acid-containing ligands.
Liu G; Xin Z; Liang H; Abad-Zapatero C; Hajduk PJ; Janowick DA; Szczepankiewicz BG; Pei Z; Hutchins CW; Ballaron SJ; Stashko MA; Lubben TH; Berg CE; Rondinone CM; Trevillyan JM; Jirousek MR
J Med Chem; 2003 Jul; 46(16):3437-40. PubMed ID: 12877578
[TBL] [Abstract][Full Text] [Related]
16. Development of a robust scintillation proximity assay for protein tyrosine phosphatase 1B using the catalytically inactive (C215S) mutant.
Skorey KI; Kennedy BP; Friesen RW; Ramachandran C
Anal Biochem; 2001 Apr; 291(2):269-78. PubMed ID: 11401301
[TBL] [Abstract][Full Text] [Related]
17. Allele-specific inhibitors of protein tyrosine phosphatases.
Hoffman HE; Blair ER; Johndrow JE; Bishop AC
J Am Chem Soc; 2005 Mar; 127(9):2824-5. PubMed ID: 15740097
[TBL] [Abstract][Full Text] [Related]
18. Structurally unique inhibitors of human mitogen-activated protein kinase phosphatase-1 identified in a pyrrole carboxamide library.
Lazo JS; Skoko JJ; Werner S; Mitasev B; Bakan A; Koizumi F; Yellow-Duke A; Bahar I; Brummond KM
J Pharmacol Exp Ther; 2007 Sep; 322(3):940-7. PubMed ID: 17538006
[TBL] [Abstract][Full Text] [Related]
19. Is RK-682 a promiscuous enzyme inhibitor? Synthesis and in vitro evaluation of protein tyrosine phosphatase inhibition of racemic RK-682 and analogues.
Carneiro VM; Trivella DB; Scorsato V; Beraldo VL; Dias MP; Sobreira TJ; Aparicio R; Pilli RA
Eur J Med Chem; 2015 Jun; 97():42-54. PubMed ID: 25938987
[TBL] [Abstract][Full Text] [Related]
20. Potent and highly selective inhibitors of the protein tyrosine phosphatase 1B.
Taing M; Keng YF; Shen K; Wu L; Lawrence DS; Zhang ZY
Biochemistry; 1999 Mar; 38(12):3793-803. PubMed ID: 10090769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
